Asthma exacerbates PE risk
Data from Taiwan show that asthma is associated with a significant increase in the risk for pulmonary embolism, particularly in patients who experience exacerbations. (Source: MedWire News - Thrombosis)
Source: MedWire News - Thrombosis - September 8, 2013 Category: Internal Medicine Source Type: news
PE presents ‘therapeutic challenge’ in COPD
Researchers have found that those patients who develop pulmonary embolism have the poorest outcomes among chronic obstructive pulmonary disease patients with venous thromboembolism. (Source: MedWire News - Thrombosis)
Source: MedWire News - Thrombosis - August 1, 2013 Category: Internal Medicine Source Type: news
Rheumatoid arthritis linked to VTE risk
Patients with rheumatoid arthritis have a significantly elevated risk for venous thromboembolism, suggest study findings published in Arthritis Care and Research. (Source: MedWire News - Thrombosis)
Source: MedWire News - Thrombosis - May 25, 2013 Category: Internal Medicine Source Type: news
Protamine–heparin complex antibodies raise concerns
Almost a third of patients treated with protamine for heparin reversal during cardiopulmonary bypass develop antibodies to circulating protamine–heparin complexes, study findings suggest. (Source: MedWire News - Thrombosis)
Source: MedWire News - Thrombosis - April 23, 2013 Category: Internal Medicine Source Type: news
WOEST supports clopidogrel only in PCI patients on anticoagulation
Publication of the WOEST trial results reaffirm the study’s major finding that antiplatelet therapy with clopidogrel alone is preferable to the use of both aspirin and clopidogrel in patients undergoing percutaneous coronary intervention who are receiving oral anticoagulant therapy. (Source: MedWire News - Thrombosis)
Source: MedWire News - Thrombosis - February 25, 2013 Category: Internal Medicine Source Type: news
Blood type, blood protein mutations influence thromboembolism risk
Findings from two Danish studies have shown that ABO blood type, both alone and in combination with the presence of factor V and prothrombin mutations, is associated with increases in risk for venous thromboembolism. (Source: MedWire News - Thrombosis)
Source: MedWire News - Thrombosis - February 21, 2013 Category: Internal Medicine Source Type: news
Rivaroxaban ruled out for extended thromboprophylaxis
The benefits of extended prophylactic anticoagulation with rivaroxaban in acutely ill hospital patients are outweighed by an increased bleeding risk, shows a study in The New England Journal of Medicine. (Source: MedWire News - Thrombosis)
Source: MedWire News - Thrombosis - February 14, 2013 Category: Internal Medicine Source Type: news
Hypercoagulable markers identified in upper arm thrombosis patients
Coagulation tests are warranted in young women undergoing surgery for subclavian vein thrombosis, especially patients with Paget-Schroetter syndrome unrelated to physical activity, say US clinicians. (Source: MedWire News - Thrombosis)
Source: MedWire News - Thrombosis - January 18, 2013 Category: Internal Medicine Source Type: news
Thromboprophylaxis does more harm than good in head and neck surgery
Patients undergoing oncologic head and neck surgery do not benefit from thromboprophylaxis, report researchers. (Source: MedWire News - Thrombosis)
Source: MedWire News - Thrombosis - January 2, 2013 Category: Internal Medicine Source Type: news
